Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rang in Aktien
#4619
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aktienkurs
$3.20
Marktkapitalisierung
$3.24B
Veränderung (1 Tag)
-2.37%
Veränderung (1 Jahr)
-11.64%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategorie
Healthcare
Kursverlauf für Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Höchster Schlusskurs: $3.15 am 2026-10-01
Niedrigster Schlusskurs: $0.24 am 2008-07-01
Niedrigster Schlusskurs: $0.24 am 2008-07-01
Kursverlauf der Aktie von Jiangsu Nhwa Pharmaceutical Co., Ltd. von 2008 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -7.86% |
| 2025 | 0.84% |
| 2024 | -6.47% |
| 2023 | 21.41% |
| 2022 | 29.91% |
| 2021 | -10.52% |
| 2020 | 65.99% |
| 2019 | 11.29% |
| 2018 | -34.33% |
| 2017 | 17.11% |
| 2016 | -13.62% |
| 2015 | 27.78% |
| 2014 | 21.35% |
| 2013 | 73.55% |
| 2012 | 33.53% |
| 2011 | -15.50% |
| 2010 | 63.69% |
| 2009 | 105.21% |
| 2008 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
